Last $20.80 USD
Change Today +0.21 / 1.02%
Volume 93.3K
CMRX On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 8:10 PM 07/21/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Kenneth I. Moch

Former Non-Executive Chairman of the Board, Synvista Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 8 board members in 1 different organizations across 6 different industries.

See Board Relationships
59--

Background*

Mr. Kenneth I. Moch, also known as Ken served as the Chief Executive Officer and President of Chimerix, Inc., since May 2010 until April 2014. Mr. Moch served as President and Chief Executive Officer of BioMedical Enterprises, Inc. since January 2009. He founded Euclidean Life Science Advisors and serves as its President. In 1995, Mr. Moch joined Alteon Inc., where he served as President and Chief Executive Officer from 1998 to 2005. He served as Managing Director of ...

Read Full Background

Corporate Headquarters*

2505 Meridian Parkway
Durham, North Carolina 27713

United States

Phone: 919-806-1074
Fax: 919-806-1146

Board Members Memberships*

Former Chairman
Former President
Director
1998-N/A
Former Non-Executive Chairman of the Board
2008-2009
Former Director, Member of the Audit Committee, Member of the Compensation Committee and Member of the Governance & Nominating Committee
2010-N/A
Former Director

Education*

BA
Princeton University
MBA
Stanford Graduate School of Business

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CMRX:US $20.80 USD +0.21

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHIMERIX INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.